• Police seek suspects in deadly birthday party shooting
  • Lawmakers launch inquires into U.S. boat strike
  • Nov. 29, 2025, 10:07 PM EST / Updated Nov. 30, 2025,…
  • Mark Kelly says troops ‘can tell’ what orders…

Be that!

contact@bethat.ne.com

 

Be That ! Menu   ≡ ╳
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics Politics
☰

Be that!

UPS Cargo Plane Crashes After Takeoff Leaving at Least 7 Dead

admin - Latest News - November 5, 2025
admin
17 views 26 secs 0 Comments



Devastating video shows the moment a UPS cargo plane crashed in Louisville, Kentucky, shortly after takeoff creating a massive fireball and spreading to several businesses on the ground. Officials say seven people were killed, including all three crew members on board. NBC’s Adrienne Broaddus reports for TODAY.



Source link

TAGS:
PREVIOUS
Democrats expand majority in Virginia House of Delegates, building on statewide wins
NEXT
Government Shutdown Becomes Longest in US History
Related Post
September 24, 2025
Sept. 23, 2025, 6:05 PM EDTBy Daniel ArkinFour Democratic lawmakers are opening a probe into Nexstar and Sinclair, two major TV station owners that are refusing to air Jimmy Kimmel’s late-night talk show amid criticism of his on-air comments about the assassination of Charlie Kirk.In a letter, first obtained by NBC News, the lawmakers asked the corporate heads of both companies for more information about their decisions to pre-empt airings of ABC’s “Jimmy Kimmel Live!” and “how those decisions may relate to regulatory issues pending with the Trump administration.”“If you suspended a late-night comedian’s show in part to seek regulatory favors from the administration, you have not only assisted the administration in eroding First Amendment freedoms but also create the appearance of a possible quid-pro-quo arrangement that could implicate federal anti-corruption laws,” the lawmakers wrote.Follow live updates here.The seven-page letter was sent by Democratic Sens. Elizabeth Warren of Massachusetts, Ron Wyden of Oregon, Ed Markey of Massachusetts and Chris Van Hollen of Maryland. It is addressed to Perry A. Sook, the chairman of Nexstar Media Group, and Christopher S. Ripley, the president and chief executive of Sinclair Broadcast Group. Together, Nexstar and Sinclair account for roughly 70 ABC affiliates across the U.S.The four Democratic lawmakers do not have subpoena power because their party does not have a majority in the U.S. Senate, but they can still demand answers from business leaders and public officials on issues tied to federal law.Nexstar and Sinclair both have pending business before the Trump administration’s Federal Communications Commission, which regulates the broadcast television industry and other key media platforms. Nexstar is seeking FCC approval for a proposed $6.2 billion merger with a rival, Tegna. Sinclair is exploring merger options for its broadcast business, according to CNBC.The lawmakers outlined eight questions for the heads of Nexstar and Sinclair, including which company executives were involved in discussions about pre-empting Kimmel’s show; what actions the companies are taking to “facilitate the Trump administration’s sign-off” on their pending deals; and whether the companies spoke with the head of the FCC or other Trump administration officials about the Kimmel decisions.Nexstar joins Sinclair in keeping Jimmy Kimmel off ABC affiliate stations03:29Representatives for Nexstar and Sinclair did not immediately respond to requests for comment.Kimmel’s late-night talk show is set to return Tuesday after he was suspended for what Disney, the owner of ABC, characterized as “ill-timed and thus insensitive” remarks about the killing of Kirk, a prominent conservative activist. “The MAGA gang [is] desperately trying to characterize this kid who murdered Charlie Kirk as anything other than one of them and doing everything they can to score political points from it,” Kimmel said during his Sept. 15 show.Kimmel’s comments set off a political firestorm. FCC Chairman Brendan Carr accused Kimmel of being part of a “concerted effort to lie to the American people” and threatened to “take action” at the regulatory level against Disney. Nexstar and Sinclair said they would yank the show from their airwaves, and Disney halted production. The suspension drew backlash from Hollywood talent and lawmakers in both parties, stoking a national debate over free speech.Disney announced Monday that “Jimmy Kimmel Live!” would return Tuesday night, ending an impasse that riveted Hollywood and Washington alike. But Nexstar and Sinclair said they would continue to pre-empt the show until further notice. “We stand by that decision pending assurance that all parties are committed to fostering an environment of respectful, constructive dialogue in the markets we serve,” Nexstar said in its news release.Carr, for his part, denied that he threatened to revoke ABC’s broadcast licenses unless Disney fired Kimmel, a vocal critic of President Donald Trump who has hosted his namesake talk show since 2003. Carr, speaking at a conference Monday, insisted that Disney, “on its own,” made a “business decision” to suspend the late-night host’s show. He also accused Democratic lawmakers of “distorting what happened here” with accusations of government coercion and censorship.Warren, Wyden, Markey and Van Hollen said they request answers to their questions by Oct. 7.Daniel ArkinDaniel Arkin is a national reporter at NBC News.
November 11, 2025
Families sue Camp Mystic over children's deaths
October 7, 2025
Trump asserts 'Democrats are like insurrectionists'
October 16, 2025
Oct. 16, 2025, 5:46 PM EDT / Updated Oct. 16, 2025, 6:01 PM EDTBy Aria BendixPresident Donald Trump on Thursday announced two policy changes aimed at making in vitro fertilization more affordable — a long-awaited follow-up to his pledges to require health insurers to cover IVF services and to an executive order aimed at lowering the cost of fertility treatments.However, the announcement was not a new rule that insurers must cover IVF. Rather, the Trump administration said that the White House has negotiated with two specialty pharmacies and a drug manufacturer to lower the cost of a commonly prescribed fertility drug that stimulates the ovaries to produce eggs.Additionally, the administration announced forthcoming guidance from the Labor, Treasury, and Health and Human Services departments that will help employers offer fertility benefits outside of major medical health insurance plans, the same way they offer dental, vision or life insurance. “We want to make it easier for all couples to have babies, raise children and start the families they have always dreamed about,” Trump said at a briefing in the Oval Office. The bulk of Thursday’s announcement focused on discounted fertility medications from drugmaker EMD Serono, which is part of the pharmaceutical giant Merck. The company said it would make its IVF drugs available at a lower cost through TrumpRx, a direct-to-consumer website operated by the federal government, starting in early 2026. “We are proud to announce that Americans will have access to our leading IVF therapies for an 84% discount off list prices,” Libby Horne, head of U.S. fertility at EMD Serono, said.Most IVF patients in the U.S. pay out of pocket for treatment, according to KFF, a nonprofit research group. Among the discounted drugs is a commonly used medication called Gonal-f, which some IVF patients take in the form of daily injections for roughly one or two weeks.Lab staff prepare small petri dishes, each holding several embryos, for cells to be extracted from each embryo to test for viability in Houston in 2024.Michael Wyke / AP fileSenior administration officials said the specialty pharmacies involved in the deal, CVS Specialty and Express Scripts’ Freedom Fertility — which they estimated account for more than 80% of the distribution of Gonal-f — agreed to reduce their expenses associated with the drug’s handling.“Upwards of 40% of the cost of IVF comes from the specialty drugs used for this treatment. Reducing these costs can have a significant impact on affordability and access,” Dr. Roger Shedlin, CEO of the fertility benefits company WIN, said in a statement.Trump’s announcement came after months of relative silence from the White House on which policies it was considering to expand IVF access. The executive order he issued in February had called for recommendations for “protecting IVF access and aggressively reducing out-of-pocket and health plan costs for IVF treatment.” Trump received a list of those recommendations in May.The new deal is part of Trump’s broader effort to bring the cost of prescription drugs in the U.S. more in line with the lowest prices charged in other wealthy countries — what’s known as the “most favored nation” pricing model.The White House has not yet negotiated lower prices on IVF drugs from other manufacturers.Sean Tipton, chief advocacy and policy officer at the American Society for Reproductive Medicine, which represents IVF providers, called the announcement a “crucial first step,” but said it still doesn’t go far enough to boost affordability.“One executive action cannot, on its own, ensure that every patient who needs IVF — which for some represents the only option to have a child — can access it,” he said.For now, senior administration officials said, medications made by EMD Serono will be discounted on TrumpRx at varying levels depending on a buyer’s income. Patients earning below 550% of the federal poverty level will be eligible for the more significant discount, the officials said.Trump campaigned last year on expanding IVF access, referring to himself at the time as the “father of IVF.” However, some conservatives and anti-abortion groups see IVF as unethical because the process often involves discarding embryos that have genetic issues or aren’t needed. The Washington Post reported in August that the administration had veered away from the idea of an IVF coverage requirement for health insurers.EMD Serono is seeking approval from the Food and Drug Administration for another fertility drug, Pergoveris, which is approved in Europe but not the U.S. Administration officials said on Thursday the FDA intends to give that application priority review status, which would expedite the process.Aria BendixAria Bendix is the breaking health reporter for NBC News Digital.
Comments are closed.
Scroll To Top
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics
© Copyright 2025 - Be That ! . All Rights Reserved